CMECOPE

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 1

Ocular Surface Diseases, Disorders, and Dysfunctions™: Volume 3, Number 1

Overview

Author(s)/Faculty: Ashley R. Brissette, MD, MSc, FRCSC; Brandon D. Ayres, MD; Christopher E. Starr, MD, FACS; Marjan Farjid, MD; Melissa Barnett, OD, FAAO, FSLS; Morgan R. Godin, MD; Paul M. Karpecki, OD, FAAO; Preeya K. Gupta, MD
Source: Healio
Type: ArticleArticles/Items: 7
Release Date: 9/8/2017Expiration Date: 9/7/2018
Credit Type: CME / COPENumber of Credits: 1.25
Cost: FreeProvider: Purdue U
Ocular surface disease (OSD) is a group of disorders commonly seen in ophthalmic practice, but it is challenging to differentially diagnose and is frequently undertreated. The consequences of undiagnosed and/or undertreated OSD can impact patient quality of life and severely affect visual acuity, especially in those undergoing cataract and/or refractive surgery. Effective diagnostics and therapeutics have been limited, but recent approvals by the US Food and Drug Administration and continued evaluation of new therapy modalities have the potential to enhance outcomes in patients with OSD. In this publication series, Ocular Surface Diseases, Disorders, & Dysfunctions™ Volume 3, expert clinicians will review and evaluate pertinent advances in the diagnosis, management, and treatment of OSD, as well as offer clinical expertise for the management of challenging case presentations.

CME/CE Information

page 1 of 10